Physician profile
Luis Gonzalez
NPI 1053591024
$28,963.86
in general payments reported to CMS, 2019-2025
13 companies · $19K in 2025
The $19K reported for 2025 was more than what 89% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,331 · 2020: $86.57 · 2021: $767 · 2022: $491 · 2023: $1,652 · 2024: $4,768 · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $4,431 · Food and Beverage: $2,957 · Consulting Fee: $1,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,800.00 |
| Travel and Lodging | $4,431.41 |
| Food and Beverage | $2,957.06 |
| Consulting Fee | $1,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $14,845.11 | 2021-2025 | Pipeline, Onyx 18, Solitaire X |
| Penumbra, INC. | $10,442.60 | 2025 | Smart Coil |
| Microvention, INC. | $2,120.99 | 2019-2025 | Stent, Web Aneurysm Embolization System |
| Medtronic USA, INC. | $357.95 | 2019-2020 | |
| Route 92 Medical, INC. | $342.44 | 2024-2025 | 8f Base Camp Sheath System |
| Depuy Synthes Sales INC. | $311.43 | 2019-2023 | Embotrap, Emboguard |
| Siemens Medical Solutions USA, INC. | $190.00 | 2024 | Artis Icono Biplane |
| Balt USA, LLC | $173.44 | 2021 | |
| Imperative Care, INC | $116.12 | 2023-2024 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Glaxosmithkline, LLC. | $24.56 | 2023 | Trelegy Ellipta, Arexvy |
| Vanda Pharmaceuticals INC. | $21.81 | 2023 | Hetlioz |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $17.41 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.